Get the Stockscreener App
2.00
1.48%
-0.03
After Hours:
1.96
-0.04
-2.00%
Senti Biosciences Inc stock is traded at $2.00, with a volume of 84,537.
It is down -1.48% in the last 24 hours and up +25.00% over the past month.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
See More
Previous Close:
$2.03
Open:
$2.03
24h Volume:
84,537
Relative Volume:
0.47
Market Cap:
$52.32M
Revenue:
$1.79M
Net Income/Loss:
$-70.90M
P/E Ratio:
-0.1287
EPS:
-15.54
Net Cash Flow:
$-34.95M
1W Performance:
-10.71%
1M Performance:
+25.00%
6M Performance:
-39.76%
1Y Performance:
-8.26%
1-Day Range:
$1.9511
$2.0855
1-Week Range:
$1.9511
$2.28
52-Week Range:
$1.26
$16.94
Senti Biosciences Inc Stock (SNTI) Company Profile
Name
Senti Biosciences Inc
Sector
Industry
Phone
(650) 239-2030
Address
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Compare SNTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
2.00 | 53.11M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | H.C. Wainwright | Buy |
| Jun-06-25 | Initiated | Laidlaw | Buy |
| Oct-07-22 | Initiated | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Stock (SNTI) Latest News
Why Senti Biosciences Inc. stock could benefit from AI revolutionJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com
Combining machine learning predictions for Senti Biosciences Inc.Market Activity Summary & Fast Gain Swing Alerts - newser.com
Is Senti Biosciences Inc. stock resilient to inflation2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025 - The Manila Times
Will a bounce in Senti Biosciences Inc. offer an exitEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com
Will Senti Biosciences Inc. stock recover faster than peersWeekly Market Summary & Safe Capital Growth Tips - newser.com
Will Senti Biosciences Inc. stock deliver shareholder valueGap Up & Free Technical Confirmation Trade Alerts - newser.com
Measuring Senti Biosciences Inc.’s beta against major indicesJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
Candlestick signals on Senti Biosciences Inc. stock todayEarnings Miss & Community Driven Trade Alerts - newser.com
Why Senti Biosciences Inc. stock appeals to analysts2025 Year in Review & Daily Stock Trend Reports - newser.com
What insider trading reveals about Senti Biosciences Inc. stock2025 Geopolitical Influence & Smart Money Movement Tracker - newser.com
Is Senti Biosciences Inc. stock attractive for ETFsWeekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
Is Senti Biosciences Inc. trending in predictive chart modelsEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
Is Senti Biosciences Inc. forming a reversal patternJuly 2025 Rallies & Verified Momentum Stock Ideas - newser.com
Applying Wyckoff theory to Senti Biosciences Inc. stock2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Strategies to average down on Senti Biosciences Inc.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
How Senti Biosciences Inc. stock benefits from global expansionWeekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
Will Senti Biosciences Inc. stock keep outperforming rivals2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-31 05:19:34 - newser.com
Published on: 2025-10-31 03:42:19 - newser.com
What analysts say about Senti Biosciences Inc stockStock Watchlist Updates & Free Dynamic Investment Techniques - earlytimes.in
Published on: 2025-10-29 02:48:48 - newser.com
Published on: 2025-10-29 00:36:43 - newser.com
Senti Biosciences Inc Stock (SNTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Senti Biosciences Inc Stock (SNTI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lu Timothy K | CEO |
Feb 06 '25 |
Sale |
4.36 |
545 |
2,376 |
82,082 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 04 '25 |
Sale |
4.07 |
1,297 |
5,279 |
8,803 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 06 '25 |
Sale |
4.37 |
182 |
795 |
8,621 |
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):